Cardona AF, Ruiz-Patino A, Recondo G, Martin C, et al. Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP). Clin Lung Cancer 2022 Jun 6. pii: S1525-7304(22)00127.
PMID: 35798634